Clinical Outcomes, Treatment Patterns, and Health Resource Utilization Among Metastatic Breast Cancer Patients with Germline BRCA1/2 Mutation: A Real-World Retrospective Study
Crossref DOI link: https://doi.org/10.1007/s12325-018-0867-x
Published Online: 2019-01-17
Published Print: 2019-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quek, Ruben G. W.
Mardekian, Jack
Funding for this research was provided by:
Pfizer Inc.
Text and Data Mining valid from 2019-01-17
Article History
Received: 20 November 2018
First Online: 17 January 2019